As other FH cases carrying both APOB/PCSK9 variants might exist, the molecular identification of FH double-heterozygotes is still essential through genetic cascade screening to provide proper diagnosis and treatment for FH. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.